Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-08

FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Montelukast sodium from Rising Pharma Holdings, Inc. under an ANDA, marking approval of a supplemental submission fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)